ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 77 filers reported holding ONCOCYTE CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $12,325 | -41.4% | 34,776 | -47.0% | 0.00% | – |
| Q4 2022 | $21,048 | -88.2% | 65,592 | -67.0% | 0.00% | – |
| Q2 2022 | $179,000 | +47.9% | 198,704 | +144.7% | 0.00% | – |
| Q1 2022 | $121,000 | -80.2% | 81,200 | -71.3% | 0.00% | – |
| Q4 2021 | $612,000 | +20.5% | 282,614 | +98.4% | 0.00% | – |
| Q3 2021 | $508,000 | -25.2% | 142,423 | +20.5% | 0.00% | – |
| Q2 2021 | $679,000 | -34.0% | 118,200 | -40.4% | 0.00% | – |
| Q1 2021 | $1,029,000 | +259.8% | 198,281 | +65.4% | 0.00% | – |
| Q4 2020 | $286,000 | +232.6% | 119,880 | +93.7% | 0.00% | – |
| Q3 2020 | $86,000 | +95.5% | 61,887 | +245.2% | 0.00% | – |
| Q1 2020 | $44,000 | -15.4% | 17,926 | -23.1% | 0.00% | – |
| Q4 2019 | $52,000 | -40.2% | 23,312 | -43.5% | 0.00% | – |
| Q3 2019 | $87,000 | -77.8% | 41,251 | -73.7% | 0.00% | – |
| Q2 2019 | $392,000 | +243.9% | 156,841 | +441.6% | 0.00% | – |
| Q1 2019 | $114,000 | +137.5% | 28,961 | +178.8% | 0.00% | – |
| Q4 2017 | $48,000 | -35.1% | 10,386 | -16.9% | 0.00% | – |
| Q1 2017 | $74,000 | – | 12,505 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 14,716,204 | $20,456,000 | 1.61% |
| PURA VIDA INVESTMENTS, LLC | 6,022,534 | $8,371,000 | 0.43% |
| P.A.W. CAPITAL CORP | 199,700 | $278,000 | 0.30% |
| Penbrook Management LLC | 229,425 | $319,000 | 0.28% |
| PERKINS CAPITAL MANAGEMENT INC | 39,725 | $55,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 201,047 | $279,000 | 0.05% |
| Private Wealth Partners, LLC | 150,000 | $209,000 | 0.02% |
| Phoenix Holdings Ltd. | 317,138 | $426,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 255,300 | $355,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 157,933 | $226,000 | 0.01% |